- Home
- FRO vs XENE Comparison
FRO vs XENE Comparison
Compare FRO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRO | XENE |
|---|---|---|
| Founded | 1985 | 1996 |
| Country | Cyprus | Canada |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.2B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FRO | XENE |
|---|---|---|
| Price | $38.79 | $61.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $37.67 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 2.0M | 1.2M |
| Earning Date | 05-22-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.85% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,496.48 |
| P/E Ratio | $34.05 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.26 | $32.78 |
| 52 Week High | $43.10 | $72.66 |
Technical Indicators
Market Signals| Indicator | FRO | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 44.96 |
| Support Level | $33.79 | $52.40 |
| Resistance Level | $39.61 | $62.91 |
| Average True Range (ATR) | 1.14 | 2.11 |
| MACD | 0.11 | -0.96 |
| Stochastic Oscillator | 73.56 | 9.03 |
Price Performance
Historical ComparisonAbout FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.